Loading...
Market
What will be the market share of Abbott's Lingo CGM in the US by end of 2024?
2
Resolution / Starting Odds
Less than 10% • 25%
10% to 20% • 25%
20% to 30% • 25%
More than 30% • 25%
Market research reports from firms like IDC, Gartner, or Abbott's official reports
Story
Abbott Launches $49 Lingo Over-the-Counter Continuous Glucose Monitor in U.S.
Sep 5, 2024, 01:16 PM
Abbott has launched its first over-the-counter continuous glucose monitor, Lingo, in the United States on Thursday. The device, priced at $49, is part of a new class of consumer-friendly biosensors designed to help users understand how their bodies respond to food, exercise, and stress. This marks a significant step in making health and wellness monitoring more accessible to the general public.
View original story
Similar markets
Less than 10% • 25%
10% to 20% • 25%
20% to 30% • 25%
More than 30% • 25%
Less than 10% • 25%
10% to 20% • 25%
20% to 30% • 25%
More than 30% • 25%
0-10% • 25%
11-25% • 25%
26-50% • 25%
More than 50% • 25%
None • 25%
1 • 25%
2 • 25%
3 or more • 25%
Below 20% • 25%
20% to 30% • 25%
30% to 40% • 25%
Above 40% • 25%
Less than 20% • 25%
20% to 40% • 25%
40% to 60% • 25%
More than 60% • 25%
Less than 10% • 25%
10% to 20% • 25%
20% to 30% • 25%
More than 30% • 25%
Less than 20% • 33%
20% - 50% • 33%
More than 50% • 34%
Less than 10% • 25%
10% to 20% • 25%
20% to 30% • 25%
More than 30% • 25%
Less than 10% • 25%
10% to 20% • 25%
20% to 30% • 25%
More than 30% • 25%
Less than 20% market share • 33%
20%-40% market share • 34%
More than 40% market share • 33%
